JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Müller, K.
Right arrow Articles by Mermod, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Müller, K.
Right arrow Articles by Mermod, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 3, 1645-1650, January 21, 2000


The Histone-interacting Domain of Nuclear Factor I Activates Simian Virus 40 DNA Replication in Vivo*

Karin Müller and Nicolas MermodDagger

From the Laboratory for Molecular Biotechnology, Institute of Animal Biology and Center for Biotechnology UNIL-EPFL, University of Lausanne, 1015 Lausanne, Switzerland

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

Efficient initiation of SV40 DNA replication requires transcription factors that bind auxiliary sequences flanking the minimally required origin. To evaluate the possibility that transcription factors may activate SV40 replication by acting on the chromatin structure of the origin, we used an in vivo replication system in which we targeted GAL4 fusion proteins to the minimally required origin. We found that the proline-rich transcriptional activation domain of nuclear factor I (NF-I), which has been previously shown to interact with histone H3, specifically activates replication. Evaluation of a series of deletion and point mutants of NF-I indicates that the H3-binding domain and the replication activity coincide perfectly. Assays with other transcription factors, such as Sp1, confirmed the correlation between the interaction with H3 and the activation of replication. These findings imply that transcription factors such as NF-I can activate SV40 replication via direct interaction with chromatin components, thereby contributing to the relief of nucleosomal repression at the SV40 origin.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

Transcription factor binding sites are often found in sequences adjacent to viral origins of replication. They stimulate replication by modulating the efficiency of replication, but not the basic mechanism of replication. Different mechanisms for the stimulation of replication by transcription factors have been proposed. For instance, on the adenovirus origin of replication, cellular transcription factors such as NF-I,1 a member of the CAAT box-binding transcription factor CTF/NF-I family of DNA-binding proteins, activate replication by recruiting the viral DNA polymerase to the origin (1-3). In other cases, replication depends on complex arrays of transcription factor binding sites, such as in polyoma and SV40. SV40 DNA replication initiates at a well-defined origin (SV40 ori) that is flanked by two auxiliary sequences. The binding motifs for the Sp1 transcription factor contained in the auxiliary sequences are required for efficient SV40 replication (4). SV40 is a relatively simple and widely used model to study the activation of cellular DNA replication because its initiation requires only one viral protein, the large T-antigen; all the other proteins needed for initiation and elongation are provided by the host cell (5). Furthermore, SV40 circular DNA is covered with nucleosomes, analogous to cellular chromatin (6).

The mechanisms allowing SV40 replication activation by transcription factors remain poorly understood. In vitro studies have suggested that transcription factors might recruit replication factors such as Replication Factor A to the origin (7, 8). Alternatively, it has been suggested that transcription factors prevent the chromatin structure from interfering with the binding of initiation factors to the replication origin, analogous to their probable role on promoters. For instance, polyomavirus and SV40 auxiliary sequences are only required in in vitro replication assays in the presence of repressive chromatin structures (9). In infected cells, the SV40 ori is free of nucleosomes in a fraction of the minichromosomes, which is thought to represent the actively replicating fraction. It was suggested that Sp1, which is necessary for efficient initiation of SV40 replication, is involved in these changes in chromatin structure (10). Interestingly, both Sp1 and NF-I have been reported to bind histone H3, suggesting an involvement of these transcription factors in chromatin remodeling (11). NF-I has been implicated in the regulation of several steroid-sensitive promoters subjected to chromatin remodeling, and was shown to mediate reconfiguration of reconstituted chromatin in vitro (11-13). In addition, NF-I binding sites adjacent to the SV40 ori core have been shown to prevent chromatin-mediated repression of DNA replication in vitro (14). Thus, NF-I and other transcription factors might function by perturbing the local distribution of nucleosomes, thereby increasing the accessibility of the origin to the replication machinery.

In this study we investigated whether transcription factors, namely NF-I, can activate SV40 replication through their interaction with chromatin components. We show that the activation domains of several transcription factors previously shown to interact with H3 also mediate SV40 replication activation. Both H3 interaction and replication were found to be similarly reduced by a single amino acid substitution in NF-I, thus strongly correlating the interaction with histone H3 with the activation of replication. This study supports the role of chromatin remodeling activities of transcription factors in the activation of SV40 replication.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

Plasmid Constructions-- The replication standard plasmid pUCSV 40ori was constructed by inserting the SalI-HindIII fragment of pSVori Mariacarmen (J. Sogo) into pUC19, cleaved with HindIII and AflIII, after filling in the SalI and AflIII site with the Klenow enzyme. For p5GAL4ori, the replication reporter plasmid, the NcoI HindIII fragment from pSVori Mariacarmen, was inserted into pCTF1 (15), cleaved with NcoI and HindIII. This intermediate vector was cut with BamHI and XbaI, and five GAL4 binding sites were inserted as a BglII-XhaI fragment from pG5BCAT (16). The sequences encoding the GAL4 fusion proteins of NF-I (11) (GAL(399-499), GAL(438-499), and GAL(486-499)) were introduced as HindIII-EcoRV fragments from the respective pSGGAL fusion expression vectors into pRSV BXB (17), cut with XbaI and HindIII, with the XbaI site filled in with the Klenow enzyme. The coding sequences for GAL(399-438), GAL(399-472), GAL(399-486), and GAL(438-472) were transferred from their pSG424 backbone as HindIII-XbaI fragments into pRSV BXB cleaved with the same enzymes. The vectors with RSV promoter-driven expression of the GAL4-NF-I fusions carrying a point mutation (GAL(399-499)YD491, GAL(399-499)YD497, and GAL(399-499)YF497) were generated by cloning the latter as HindIII and blunt-ended AflIII fragments into pRSV BXB cleaved with HindIII and Klenow-repaired BamHI.

For pRSV GAL(479-499)wt and the point mutation thereof, GAL(479-499)YD497, the relevant fragments were removed from their parental pSG GAL4 fusion vector as HindIII and Klenow-repaired BamHI fragments and cloned into the HindIII and Klenow-repaired AflIII-cut vector pRSV BXB. Coding sequences for the fusions GALSp1(132-243), GALOct2(99-161), and GALAp2(31-76) were removed from their pSG424 backbone (11, 18) by HindIII and XbaI and cloned into HindIII-XbaI-cut pRSV BXB. pRSV GALVP16(437-445) was generated by inserting the double-stranded oligonucleotide coding for amino acids 437-445 of the VP16 activation domain into pSG424, opened with EcoRI and XbaI. This GAL fusion sequence was cloned into the HindIII-XbaI vector fragment of pRSV BXB as a HindIII-XbaI fragment.

The construction of pMLV-VP-H3(10-136) has been described previously (11).

Cell Culture and Transfection-- For replication assays, COS7 cells were electroporated with a DNA mixture containing 1 µg of pUCori replication standard plasmid, 10 µg of p5GAL4ori replication reporter, and 10 µg of RSV expression vector. Sonicated salmon sperm DNA (Sigma) was added to a total of 50 µg of transfected DNA. The medium was supplemented with 50 µCi/ml [3H]thymidine. Cells were harvested 36 h after transfection, and plasmid DNA was extracted using the QIAQUICK plasmid extraction kit according to the supplier's instructions (QIAGEN). DNA was eluted from the columns with 50 µl of H2O. Extracted plasmids were linearized by BamHI and separated on a 0.6% agarose gel. Plasmid bands were excised and subjected to scintillation counting in Hionic Fluor R (Packard) to quantify the incorporated radiolabeled thymidine. The value obtained for the reporter plasmid was normalized to that obtained for the standard plasmid. For CAT assays, COS7 cells were co-transfected with three plasmids: (a) an expression vector for the indicated GAL4 fusions, (b) an expression vector for VP16-transcriptional activation domain alone (VP) or an expression vector fused to amino acids 10-136 of histone H3 (VP-H3), and (c) the G5BCAT reporter construct. Cell extracts were prepared with lysis buffer (Promega), and the assays were performed as described previously (11). All figures display the mean of at least three experiments.

Gel Mobility Shift Assays-- For bandshift analysis of GAL fusion proteins, transiently transfected COS7 cells were harvested 36 h after transfection, washed once in 1× phosphate-buffered saline, and lysed in 100 µl of extraction buffer (20 mM Tris, pH 7.5, 20% glycerol, 500 mM KCl, 1 mM dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride) by repeated freeze-thaw cycles, as described previously (19). Whole cell lysates were normalized for total protein concentration. 4 µg of total protein extract were incubated in 20 µl of extraction buffer for 10 min at room temperature with a 32P end-labeled double-stranded DNA probe containing the 17-base pair GAL4 binding site (5'-GATCCGGGTCGGAGTACTGTCCTCCGACTGC-3'). Protein-DNA complexes were separated from free probe on native 4% polyacrylamide gels as described in Ref. 20 and revealed by phosphorimaging (Molecular Dynamics).

    RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

To evaluate the role of transcription factors in the activation of SV40 replication, COS7 cells were transfected with a replication reporter plasmid containing five GAL4 binding sites adjacent to the SV40 ori core, p5GALori, along with chimeric cDNA expression vectors for GAL fusion proteins. These encode the DNA binding and dimerization domain of the yeast GAL4, either alone (amino acids 1-147; GAL DBD) or fused to the coding sequences of the transcriptional activation domains of CTF/NF-I (amino acids 399-499, GAL Pro) or Sp1 (amino acids 132-243, GAL Sp1) (Fig. 1A). A plasmid with the full origin of replication, including both auxiliary sequences, was used as an internal reference plasmid for transfection and replication (Fig. 1A, pUCori). SV40 DNA replication was assayed by the addition of [3H]thymidine to the growth medium and by the extraction of radiolabeled replicated DNA. To ascertain that the recovered radiolabeled plasmids were true replication products, they were digested with DpnI, which only cleaves methylated DNA that has not been replicated. As an additional control, a digestion with MboI was performed (Fig. 1B) because MboI is dam methylation sensitive and cuts only non-methylated DNA. The recovered plasmids are cleaved by MboI, but not by DpnI, and are therefore replication products.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 1.   Diagram of SV40 origin constructs and in vivo assay for DNA replication. A, anatomy of the SV40 origin of replication and reporter plasmid used in this study. The SV40 origin region of pUCori, the construction used as the reference plasmid in transfections, is shown. The nucleotide map positions of SV40 minichromosomes and relevant restriction sites are indicated at the bottom. The origin of DNA replication consists of the origin core (nucleotides 31-5209) and auxiliary sequences aux-1 (nucleotides 5208 to 5193) and aux-2 (nucleotides 30-72). aux-2 contains the GC-rich recognition sequence for transcription factor Sp1 (5'-GGGCGG-3'). The AT-rich region comprises the TATA box for early transcribed viral genes. Bidirectional DNA replication starts from the DNA unwinding element (DUE). T-antigen binds mainly to the ori core (ORE; origin recognition element) and the aux-1 region. In plasmid p5GALori, five binding sites for the yeast GAL4 protein were inserted. B, replicated low molecular weight DNA was extracted from transfected COS7 cells as described under "Materials and Methods." Plasmids were linearized with HindIII, with or without either DpnI (to eliminate the non-replicated DNA) or MboI. Plasmids were resolved by electrophoresis and detected by autoradiography.

The presence of the five GAL4 binding sites had no influence per se on the basal replication activity of the modified replication origins. No difference in replication activity was detected between the two replication reporter plasmids p5GALori and pCori, a plasmid in which the aux-2 sequence is deleted (data not shown). The proline-rich transcriptional activation domain of CTF/NF-I fused to GAL (Fig. 1B, GAL Pro) efficiently activated replication of p5GALori. The expression of the DNA binding domain of GAL4 (GAL DBD) had a weak but significant activation effect on SV40 replication in the presence of GAL4 binding sites, consistent with previously published results (21, 22). In the absence of binding sites, GAL DBD and other GAL4 fusions had no effect on replication (data not shown).

H3-interacting Transcriptional Activation Domains Activate Replication-- It has been proposed that Sp1 and NF-I bind histone H3 and reorganize chromatin. Oct2, but not VP16, was also found to interact with histone H3 in two-hybrid assays (11). Thus, the activation domains of the latter transcription factors were tested for their capacity to activate replication using the same experimental approach as that used for NF-I. The activation by GAL NF-I was fixed as the reference level of replication and is used in all comparisons below. Whereas GAL Oct2 and GAL Sp1 stimulated replication, they did so to a lesser extent than GAL NF-I. Activation by these transcription factors was not due to the mere presence of a transcriptional activation domain because expression of a GAL fusion containing the VP16 activation domain or a portion thereof did not result in detectable replication (Fig. 2A; data not shown). Activation of replication by GAL Sp1 was expected because the aux-2 sequence contains Sp1 binding sites (23), and replacement of the aux-2 sequence with artificial Sp1 binding sites has been reported to activate SV40 replication in CV1 cells (24). Activation of replication by GAL Oct2 is also consistent with the previous finding that Oct binding sites, which are found in the enhancer sequence of the SV40 promoter, can substitute for aux-2 when adjacent to the A/T-rich element of the ori core (4, 25). NF-I and Oct2 may therefore substitute for Sp1 in replication activation by using the same basic mechanism. However, the activation domain of VP16 did not activate replication in our assay in COS7 cells, indicating that the presence of a potent transcriptional activation domain is not sufficient for replication activation. This suggests that it is not transcriptional activity per se that activates SV40 replication and that another activity is required. Thus, there is a direct correlation between the potential of the activation domains to activate SV40 replication and the ability of the activation domains to interact with histone H3.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 2.   The transactivation domains of NF-I, Sp1, and Oct2 activate replication at the SV40 origin and interact with histone H3 in vivo. A, the proline-rich domain of NF-I activates replication from the SV40 origin. COS7 cells were electroporated with pUCori and p5GALori and with expression vectors for GAL4 fusion proteins containing transcriptional activation domains of different transcription factors. Replicated DNA was quantitated as described under "Materials and Methods." Replication of the test plasmid (p5GALori) was normalized to that of the internal standard, pUCori. The replication measured in cells expressing GAL-NF-I was set as 100%. B, the transcriptional activation domains of NF-I, Sp1, and Oct2 interact with histone H3 in COS7 cells. COS7 cells were transfected with the G5BCAT reporter construct, expression vectors for the indicated GAL4 fusions, and a MLV expression vector for VP16 transcriptional activation domain, either alone (VP) or fused to amino acids 10-136 of histone H3 (VP-H3). Lanes with VP show the basal transcriptional activity of each of the transcription factors, whereas lanes with VP-H3 express the increase in transcriptional activity resulting from the interaction between H3 and the indicated transcription factor. CAT activities were determined as described previously (11). The CAT value obtained with cells expressing GAL-NF-I was set as 100%. The regions of the transcriptional activation domains tested are indicated. C, GAL fusion proteins are well expressed in COS7 cells, and expression of H3-VP16 does not significantly affect the GAL fusion expression level. COS7 cells were transiently transfected with vectors expressing the indicated GAL4 fusion proteins, together with expression vectors for H3VP16 or VP16. Cell lysates were analyzed for GAL4 DNA binding activity using a gel mobility shift assay; equal amounts of total protein were used in each lane. mock, mobility shift assays performed with lysates from cells transfected with empty expression vectors.

To test for the interaction of these fusion proteins in COS7 cells, two-hybrid transcription experiments were performed in parallel to the replication assays. COS7 cells were transfected with the CAT reporter construct, expression vectors for the indicated GAL fusion proteins, and expression vectors for the VP16 activation domain, either alone (VP) or fused to mouse histone H3.3 (VP-H3; Fig. 2B). An interaction between a GAL fusion protein and H3 in VP-H3 recruits the full-length VP16 transcriptional activation domain to the promoter, thus leading to higher levels of transcription. When assayed for transcriptional activity with VP16 alone, all GAL4 fusions activated transcription, and the most potent of all was GAL VP16, as seen previously (11). In the two-hybrid assay, the proline-rich activation domain of NF-I interacts efficiently with histone H3 in COS7, as do the activation domains of Sp1 and Oct2. However, no interaction between the acidic transcriptional activation domain of VP16 and the VP16-H3 fusion could be detected.

Control experiments were performed to rule out the possibility that different activation levels may actually be due to different expression levels of the activator proteins (Fig. 2C). Gel mobility shift assays demonstrated that all the fusion proteins were expressed at comparable levels and that the presence of H3-VP16 had no effect on the expression levels of the GAL4 fusion proteins. We find a close correlation between the H3 interaction and replication activation. The three transcription factors that interacted with histone H3 also significantly activated SV40 replication, whereas both VP16 and GAL DBD did not significantly activate replication and did not interact with histone H3 in the two-hybrid assay. Together, these data suggest that the presence of a strong transcriptional activation domain, as seen in GAL VP16, is not sufficient for replication activation and that the other domains induce SV40 replication by interacting with H3.

Activation of Replication by Two NF-I Subdomains-- Six deletion mutants of the proline-rich domain of NF-I were used to determine more precisely which of its subdomains activate the SV40 origin of replication. The C-terminal deletion mutants GAL(399-472) and GAL(399-438) activated replication but did so less efficiently than the full-length activation domain. This indicates that part of the replication activity maps to the C terminus of the NF-I activation domain. Further deletion of the N-terminal portions of the NF-I transcriptional activation domain, as seen in GAL(438-472), resulted in the loss of all activation potential. Thus, a second part of the replication activation potential of the proline-rich domain resides in the N-terminal portion. Indeed, N-terminal deletion mutants GAL(438-499), GAL(472-499), and GAL(486-499) mediated reduced replication as compared with the full-length domain (Fig. 3A). The loss of activation potential of GAL(438-499) and GAL(399-472) compared with GAL(399-438) and GAL(486-499) is most likely due to the presence of a central inhibitory subdomain (amino acids 438-472). These results indicate that both the C- and N-terminal portions of the NF-I transcriptional activation domain are required for full activation of the replication origin. In contrast, the central portion of the proline-rich domain has no detectable effect on replication activity.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 3.   Two subregions of the NF-I proline-rich domain mediate replication and interaction with histone H3 in COS7 cells. A, COS7 cells transfected with the indicated deletion mutants of the CTF/NF-I transcriptional activation domain fused to the GAL4 DNA binding domain, and DNA replication was assayed as described in the Fig. 2 legend. Replication activity was normalized to that of the internal standard plasmid, pUCori, and the value obtained for cells expressing the Gal-NF-I and VP16-histone H3 fusions was set as 100%. B, the C-terminal part of the proline-rich domain of CTF/NF-I mediates interaction with histone H3 in COS7 cells. COS7 cells were transfected as described in the Fig. 2 legend with the deletion mutants of the transcriptional activation domain indicated. CAT activity was assessed 36 h after transfection. C, bandshift analysis of GAL4 fusion of NF-I deletion mutants. The experiment was performed as described in the legend to Fig. 2C.

The same deletion mutants were used to map the region of GAL(399-499) that interacts with histone H3 in the two-hybrid assay. The assays for H3 interaction and replication activation were performed in the same transfections to allow a direct comparison of the results. The C-terminal deletion mutants GAL(399-472) and GAL(399-438) show strongly reduced transcriptional activation, 30- and 20-fold lower than that of GAL(399-499) (Fig. 3B). However, their interaction with H3 decreased but remained detectable, in keeping with their transcriptional activity. Conversely, the N-terminal deletion mutant GAL(438-499) showed both reduced transcriptional activity and H3 binding activity. As seen before, the expression of GAL4 fusions was not affected by the coexpression of the histone fusion constructs (Fig. 3C). These data indicate that two NF-I domains interact with H3 and mediate replication activation. One domain maps to the 13 C-terminal amino acids and is similar to the histone H3-interacting domain first identified in mouse fibroblastic cells (11). Moreover, GAL(472-499) and GAL(486-499) only modestly activate transcription on their own, but they show high levels of activity when assayed for interaction with the VP-H3 fusion protein and replication activation. In addition, we identified another portion of the proline-rich domain that also shows interaction with histone H3. This second histone H3-interacting domain activated SV40 replication to approximately the same extent as the C terminus, yet it did not significantly activate transcription on its own. Deletion of both the C- and N-terminal domains in mutant GAL(438-472) was required to inhibit both interaction with histone H3 and replication activation.

Overall, the data indicate a dual role for C- and N-terminal extremities of the NF-I transcriptional activation domain in histone H3 interaction and replication activation and imply that interaction with the histone, rather than mere transcriptional activation, confers SV40 ori activation by NF-I.

A NF-I Point Mutant Inhibits both H3 Interaction and DNA Replication-- The C-terminal portion of the transcriptional activation domain is clearly one determinant of H3 interaction and replication activation. To further evaluate the role of this domain, we tested three GAL NF-I fusions bearing single point mutations at the C terminus.

GAL(399-499, Y491D) (tyrosine 491 changed to aspartate) and GAL(399-499, Y497F) (tyrosine 497 changed to phenylalanine) efficiently activated both replication and transcription, and interaction with VP16-H3 did not significantly differ from wild type GAL(399-499) (Fig. 4). In contrast, the protein bearing a mutation of tyrosine to aspartate at position 497, GAL(399-499, Y497D), abolished the activation of p5GALori replication. Transcriptional activation and histone interaction were also similarly reduced with this mutation (Fig. 4B). Further deletion of the N-terminal H3 interaction domain in the Y497D mutant abolished H3 interaction and replication activation, as expected (data not shown). Overall, these results provide evidence that the proline-rich domain of NF-I activates SV40 replication and further implicate the interaction with histone H3 in SV40 replication activation.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 4.   Activation of replication is abolished by a point mutant that markedly affects transcription. A, COS7 cells were transfected with the replication reporter plasmid, p5GALori, the internal standard plasmid, pUCori, and expression vectors for GAL-NF-I fusion proteins containing either the wild type NF-I proline-rich domain or the far C-terminal portion of NF-I transcriptional activation domain bearing point mutations. The tyrosine at position 491 was either left unchanged (GAL 399-499 W.T.) or mutated to aspartic acid (GAL 399-499 Y491D). The tyrosine at position 497 was changed to either aspartic acid (GAL 399-499 Y497D) or phenylalanine (GAL 399-499 Y497F). Radiolabeling, cell harvesting, and quantification of the replicated plasmids were performed as described in the Fig. 2 legend. B, COS7 cells were transfected with G5BCAT, CMVbeta gal, the vector coding for either VP-H3 or VP alone, and expression vectors for GAL-NF-I bearing point mutations in the C-terminal portion of the transcriptional activation domain, as specified in the figure. CAT activity was determined 36 h after transfection and is expressed relative to the normalized CAT activity obtained for cells expressing wild type GAL(399-499), which was set as 100. C, bandshift analysis of GAL4 fusions of NF-I point mutants. The experiment was performed as described in the legend to Fig. 2C.

Conclusions-- Previous studies have indicated that NF-I can remodel chromatin in vitro, whereas Sp1 has been suggested to maintain the SV40 origin nucleosome-free (14, 26). These findings, together with the association of chromatin remodeling and transcriptional activation at many promoters (27-29), may thus point to chromatin remodeling as a common mechanism for the activation of both transcription and replication. In both cases, chromatin structure alteration by the action, direct or indirect, of transcription factors would be an early step in activation. It is interesting to note that the H3-binding domain of NF-I is capable of restructuring the chromatin of target promoters and concomitantly prevents heterochromatic silencing in yeast.2 Therefore, the binding of histone H3 by NF-I may be the key step by which this transcription factor overcomes chromatin repression on both promoters and replication origins.

    ACKNOWLEDGEMENTS

We are grateful to J. Sogo for pSVori Mariacarmen and to M. Zahn and L. Hunt for critical reading of the manuscript.

    FOOTNOTES

* This work was supported by the Swiss National Science Foundation, the Etat de Vaud, and the University of Lausanne 450th Anniversary Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Laboratory of Molecular Biotechnology, Center for Biotechnology UNIL-EPFL, Department of Chemistry, Swiss Federal Institute of Technology-Lausanne, 1015 Lausanne, Switzerland. E-mail: nicolas.mermod@iba.unil.ch.

2 C. Boscheron, K. Müller, K. Carmine-Simmen, N. Mermod, and E. Gilson, manuscript in preparation.

    ABBREVIATIONS

The abbreviations used are: NF-I, nuclear factor I; RSV, Rous sarcoma virus; CAT, chloramphenicol acetyltransferase; CTF, CAAT box-binding transcription factor.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES

1. Nagata, K., Guggenheimer, R. A., Enomoto, T., Lichy, J., and Hurwitz, J. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 6438-6442[Abstract/Free Full Text]
2. Mul, A. M., and van der Vliet, P. C. (1992) EMBO J. 11, 751-760[Medline] [Order article via Infotrieve]
3. Armentero, M. T., Horwitz, M. S., and Mermod, N. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 11537-11541[Abstract/Free Full Text]
4. Guo, Z., Gutierrez, C., Heine, U., Sogo, J. M., and DePamphilis, M. L. (1989) Mol. Cell. Biol. 9, 3593-3602[Abstract/Free Full Text]
5. Kelly, T. J. (1988) J. Biol. Chem. 263, 17889-17892[Free Full Text]
6. Cremisi, C., Pignatti, F., Croissant, O., and Yaniv, M. (1976) J. Virol. 17, 204-211[Abstract/Free Full Text]
7. Li, R., and Botchan, M. R. (1993) Cell 73, 1207-1221[CrossRef][Medline] [Order article via Infotrieve]
8. He, Z., Brinton, B. T., Greenblatt, J., Hassell, J. A., and Ingles, C. J. (1993) Cell 73, 1223-1232[CrossRef][Medline] [Order article via Infotrieve]
9. Majumder, S., Miranda, M., and DePamphilis, M. (1993) EMBO J. 12, 1131-1140[Medline] [Order article via Infotrieve]
10. Gruss, C., and Sogo, J. M. (1992) Bioessays 14, 1-8[CrossRef][Medline] [Order article via Infotrieve]
11. Alevizopoulos, A., Dusserre, Y., Tsai-Plugfelder, M., von der Weid, T., Wahli, W., and Mermod, N. (1995) Genes Dev. 9, 3051-3066[Abstract/Free Full Text]
12. Archer, T., Cordingley, M., Wolford, R., and Hager, G. (1991) Mol. Cell. Biol. 11, 688-689[Abstract/Free Full Text]
13. Schild, C., Claret, F. X., Wahli, W., and Wolffe, A. P. (1993) EMBO J. 12, 423-433[Medline] [Order article via Infotrieve]
14. Cheng, L., and Kelly, T. J. (1989) Cell 59, 541-551[CrossRef][Medline] [Order article via Infotrieve]
15. Mermod, N., O'Neill, E. A., Kelly, T. J., and Tjian, R. (1989) Cell 58, 741-753[CrossRef][Medline] [Order article via Infotrieve]
16. Lillie, J. W., and Green, M. R. (1989) Nature 338, 39-44[CrossRef][Medline] [Order article via Infotrieve]
17. Bruder, J. T., Heidecker, G., and Rapp, U. R. (1992) Genes Dev. 6, 545-556[Abstract/Free Full Text]
18. Seipel, K., Georgiev, O., and Schaffner, W. (1992) EMBO J. 11, 4961-4968[Medline] [Order article via Infotrieve]
19. Martinez, E., Dusserre, Y., Wahli, W., and Mermod, N. (1991) Mol. Cell. Biol. 11, 2937-2945[Abstract/Free Full Text]
20. Carey, M., Kakidani, H., Leatherwood, J., Mostashari, F., and Ptashne, M. (1989) J. Mol. Biol. 209, 423-432[CrossRef][Medline] [Order article via Infotrieve]
21. Cheng, L., Workman, J. L., Kingston, R. E., and Kelly, T. J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 589-593[Abstract/Free Full Text]
22. Bennett-Cook, E. R., and Hassell, J. A. (1991) EMBO J. 10, 959-969[Medline] [Order article via Infotrieve]
23. Kelman, Z., and O'Donnell, M. (1994) Curr. Opin. Genet. Dev. 4, 185-195[CrossRef][Medline] [Order article via Infotrieve]
24. Lednicky, J., and Folk, W. R. (1992) J. Virol. 66, 6379-6390[Abstract/Free Full Text]
25. Lee-Chen, G. J., and Woodworth-Gutai, M. (1986) Mol. Cell. Biol. 6, 3086-3093[Abstract/Free Full Text]
26. Sogo, J. M., Stahl, H., Koller, T., and Knippers, R. (1986) J. Mol. Biol. 189, 189-204[CrossRef][Medline] [Order article via Infotrieve]
27. Beato, M., and Eisfeld, K. (1997) Nucleic Acids Res. 25, 3559-3563[Abstract/Free Full Text]
28. Wolffe, A. P. (1994) Trends Biochem. Sci. 19, 240-244[CrossRef][Medline] [Order article via Infotrieve]
29. Kadonaga, J. D. (1998) Cell 92, 307-313[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
E. M. Johansson, M. Kannius-Janson, A. Gritli-Linde, G. Bjursell, and J. Nilsson
Nuclear Factor 1-C2 Is Regulated by Prolactin and Shows a Distinct Expression Pattern in the Mouse Mammary Epithelial Cells during Development
Mol. Endocrinol., April 1, 2005; 19(4): 992 - 1003.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ferrari, K. C. Simmen, Y. Dusserre, K. Muller, G. Fourel, E. Gilson, and N. Mermod
Chromatin Domain Boundaries Delimited by a Histone-binding Protein in Yeast
J. Biol. Chem., December 31, 2004; 279(53): 55520 - 55530.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Lefevre, S. Melnik, N. Wilson, A. D. Riggs, and C. Bonifer
Developmentally Regulated Recruitment of Transcription Factors and Chromatin Modification Activities to Chicken Lysozyme cis-Regulatory Elements In Vivo
Mol. Cell. Biol., June 15, 2003; 23(12): 4386 - 4400.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. B. Hebbar and T. K. Archer
Nuclear Factor 1 Is Required for Both Hormone-Dependent Chromatin Remodeling and Transcriptional Activation of the Mouse Mammary Tumor Virus Promoter
Mol. Cell. Biol., February 1, 2003; 23(3): 887 - 898.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
A.-Y. Xie, V. P. Bermudez, and W. R. Folk
Stimulation of DNA Replication from the Polyomavirus Origin by PCAF and GCN5 Acetyltransferases: Acetylation of Large T Antigen
Mol. Cell. Biol., November 15, 2002; 22(22): 7907 - 7918.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
G. Liao, F. Y. Wu, and S. D. Hayward
Interaction with the Epstein-Barr Virus Helicase Targets Zta to DNA Replication Compartments
J. Virol., September 15, 2001; 75(18): 8792 - 8802.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. J. Turner and M. E. Woodworth
DNA Replication Efficiency Depends on Transcription Factor-Binding Sites
J. Virol., June 15, 2001; 75(12): 5638 - 5645.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Müller, K.
Right arrow Articles by Mermod, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Müller, K.
Right arrow Articles by Mermod, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.